We recently participated in the seed round of Digi-Prex, as it graduated from Y Combinator’s most recent batch. The company raised it from a group of highly-influential investors that include YC, Khosla, SV Angel and the likes.
Digi-Prex runs an eponymous online subscription pharmacy in Hyderabad and serves patients with chronic diseases. Patients share their prescription with Digi-Prex through WhatsApp and the startup’s workers then deliver the medication to them on a recurring cycle. Digi-Prex also helps patients better track when they need a new supply of medicine, and checks if they are seeing improvements. The startup has amassed thousands of customers in Hyderabad.
Pharma delivery remains a low-penetrated segment in Indian e-commerce market, and has huge potential for growth. We’re bullish about what Dig-Prex can achieve in this domain.
Read the news here at Techcrunch.